Keyphrases
COVID-19
100%
COVID-19 Patients
64%
Complement Factors
49%
Immunophenotyping
49%
Cytokine Hemoadsorption
49%
Interleukin-6
47%
High Risk
39%
Clinical Laboratory
37%
Complement System
33%
Compound Heterozygous mutation
33%
Survival Prediction
30%
Machine Learning
30%
Hypercytokinemia
30%
Rescue Therapy
30%
Patients with COVID-19
29%
C5 Deficiency
28%
Hospital Admission
28%
Recurrent Infection
28%
Selective Immunoglobulin A Deficiency
24%
Familial Screening
24%
Plateaued
24%
IgG Subclasses
24%
Meningococcal Disease
24%
Complement Component 5
24%
Complement Proteins
24%
Turbidimetric
24%
Immunoglobulin Protein
24%
IgG2
24%
Pediatric Reference Intervals
24%
T-cell Receptor Excision Circles
24%
Protein Electrophoresis
24%
African Families
24%
Hereditary Angioedema
24%
SERPING1 Gene
24%
Extranodal NK-T-cell Lymphoma
24%
COVID-19 Pneumonia
24%
Anti-SARS-CoV-2 Antibodies
24%
Prognostic Biomarker
24%
Disease Progression
24%
Angiotensin-converting Enzyme 2 (ACE2)
24%
Encapsulated Bacteria
24%
Sub-Saharan Africa
24%
Severe Respiratory Failure
24%
IgG4-related Disease (IgG4-RD)
24%
Predictive Models
24%
Kappa Free Light Chains
24%
Laboratory Standards
24%
Novel mutation
24%
Late Diagnosis
24%
Laboratory Parameters
24%
Medicine and Dentistry
COVID-19
82%
Severe Acute Respiratory Syndrome Coronavirus 2
62%
Cytokine
53%
Complement Factor I
49%
Factor I Deficiency
49%
Hemadsorption
49%
Biological Marker
45%
Interleukin 6
35%
Meningococcal Disease
33%
Rescue Therapy
30%
Cytokine Storm
30%
Infection
29%
Complement Component C5
24%
Immunoglobulin A Deficiency
24%
Respiratory Failure
24%
NK T Cell Lymphoma
24%
Laboratory Test
24%
Disease Exacerbation
24%
Angiotensin Converting Enzyme 2
24%
Cohort Analysis
24%
Protein Electrophoresis
24%
Capillary
24%
Hemophagocytic Syndrome
24%
Fibrinogen
22%
Thorax Radiography
18%
Diseases
16%
Recurrent Infection
16%
Ferritin
16%
Complement System
14%
Electrophoresis
13%
SOFA Score
12%
Acute Respiratory Failure
12%
Clinical Management
12%
Hemodynamic
12%
Shock (Circulatory)
12%
Retrospective Study
10%
Interleukin 10
10%
Prevalence
9%
Disease Severity
8%
Meningitis
8%
C Reactive Protein
8%
Intensive Care Unit
8%
Nonalcoholic Fatty Liver
8%
Exon
8%
Serositis
8%
Complement Deficiency
8%
Isoetarine
8%
Gene Sequence
8%
Infancy
8%
Nucleotide
8%
Immunology and Microbiology
COVID-19
74%
Complement Factor I
49%
Complement System
37%
Exon
33%
Reference Value
28%
Complement Component 5
24%
Complement Membrane Attack Complex
24%
Light Chain
24%
Laboratory Test
24%
Cell Population
24%
Oligoclonal Band
24%
McDonald Criteria
24%
Intravenous Immunoglobulin
24%
Immunoglobulin A
24%
T-Cell Receptor Excision Circles
24%
Capillary
24%
Meningitis
24%
Interleukin 6
22%
Autosomal Recessive Inheritance
20%
Complement Deficiency
20%
Immunity
19%
Prevalence
19%
Cytokine
19%
Monocyte
16%
CD4
16%
Vaccination Policy
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Neisseria
15%
Gene Frequency
15%
Immunology
14%
Immunoglobulin D
12%
Immunoglobulin G2
12%
Complex Formation
12%
Immunoglobulin G4
12%
Serotype
12%
Innate Immune System
12%
Lectin
12%
Ferritin
12%
Immunoglobulin M
12%
Complement
12%
Opsonization
12%
Heterozygote
12%
Inheritance
12%
Immunodeficiency
11%
Immune Response
9%
Immunoglobulin G3
8%
Gene Sequence
8%
Non-Alcoholic Fatty Liver Disease
8%
Dendritic Cell
8%
Arm
8%
